Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Inventory Average: 2014-2025

Historic Inventory Average for Ocular Therapeutix (OCUL) over the last 11 years, with Sep 2025 value amounting to $3.3 million.

  • Ocular Therapeutix's Inventory Average rose 31.81% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 31.81%. This contributed to the annual value of $2.7 million for FY2024, which is 24.91% up from last year.
  • According to the latest figures from Q3 2025, Ocular Therapeutix's Inventory Average is $3.3 million, which was up 3.47% from $3.2 million recorded in Q2 2025.
  • In the past 5 years, Ocular Therapeutix's Inventory Average ranged from a high of $3.3 million in Q3 2025 and a low of $1.1 million during Q2 2021.
  • In the last 3 years, Ocular Therapeutix's Inventory Average had a median value of $2.5 million in 2024 and averaged $2.6 million.
  • Data for Ocular Therapeutix's Inventory Average shows a peak YoY surged of 62.58% (in 2023) over the last 5 years.
  • Ocular Therapeutix's Inventory Average (Quarterly) stood at $1.2 million in 2021, then surged by 42.35% to $1.8 million in 2022, then increased by 29.64% to $2.3 million in 2023, then grew by 19.36% to $2.7 million in 2024, then surged by 31.81% to $3.3 million in 2025.
  • Its Inventory Average was $3.3 million in Q3 2025, compared to $3.2 million in Q2 2025 and $3.2 million in Q1 2025.